サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1530931

ホルモン補充療法市場：世界の産業分析、規模、シェア、成長、動向、2024～2034年予測

Hormone Replacement Therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

出版日
ページ情報
英文 164 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
ホルモン補充療法市場：世界の産業分析、規模、シェア、成長、動向、2024～2034年予測
出版日: 2024年06月20日
発行: Transparency Market Research
ページ情報: 英文 164 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ホルモン補充療法市場-調査範囲

TMRの調査レポート「ホルモン補充療法の世界市場」は、2024～2034年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2024年を基準年、2034年を予測年として、2018～2034年までの世界のホルモン補充療法市場の収益と予測を提供しています。また、2024～2034年までの世界のホルモン補充療法市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、ホルモン補充療法市場を推察しました。

市場スナップショット
2023年の市場規模 210億米ドル
2034年の市場規模 388億米ドル
CAGR 5.7%

当レポートでは、世界のホルモン補充療法市場の競合情勢について調査しています。世界のホルモン補充療法市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTなどが、本レポートで紹介されている世界のホルモン補充療法市場における参入企業の属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の市場分析と予測、2020～2034年

第5章 主要洞察

  • パイプライン分析
  • 主要製品/ブランド分析
  • 主要M&A
  • COVID-19による産業への影響

第6章 世界の市場分析と予測：治療タイプ別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：治療タイプ別、2020～2034年
    • ヒト成長ホルモン（HGH）補充療法
    • 甲状腺補充療法
    • テストステロン補充療法
    • ドーパミン作動薬
    • ソマトスタチン類似体
    • その他（副甲状腺など）
  • 市場の魅力：治療タイプ別

第7章 世界の市場分析と予測：投与経路別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：投与経路別、2020～2034年
    • 経口
    • 非経口
    • 経皮
  • 市場の魅力：投与経路別

第8章 世界の市場分析と予測：適応疾患別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：適応疾患別、2020～2034年
    • 閉経
    • 甲状腺機能低下症
    • 男性性腺機能低下症
    • 成長ホルモン欠乏症
    • 副甲状腺機能低下症
  • 市場の魅力：適応疾患別

第9章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主要調査結果・発展
  • 市場金額予測：流通チャネル別、2020～2034年
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場の魅力：流通チャネル別

第10章 世界の市場分析と予測：地域別

  • 主要調査結果
  • 市場金額予測：地域別、2020～2034年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第11章 北米の市場分析と予測

第12章 欧州の市場分析と予測

第13章 アジア太平洋の市場分析と予測

第14章 ラテンアメリカの市場分析と予測

第15章 中東・アフリカの市場分析と予測

第16章 競合情勢

  • 市場企業-競合マトリックス（企業階層と規模別）
  • 市場シェア分析：企業別（2023年）
  • 企業プロファイル
    • Novartis AG
    • Abbott Laboratories
    • Mylan N.V.
    • Merck & Co., Inc.
    • Bayer AG
    • Pfizer Inc.
    • Novo Nordisk A/S
    • QuatRx Pharmaceuticals Co.
    • Teva Pharmaceutical Industries Ltd.
    • Amgen Inc.
    • Eli, Lilly and Company
    • AbbVie Inc.
    • Noven Pharmaceuticals
図表

List of Tables

  • Table 01: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 02: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 03: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 04: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 05: Global Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Region, 2020-2034
  • Table 06: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country, 2020-2034
  • Table 07: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 08: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 09: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 10: North America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 11: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 12: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 13: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 14: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 15: Europe Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 16: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 17: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 18: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 19: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 20: Asia Pacific Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 21: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 22: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 23: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 24: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 25: Latin America Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034
  • Table 26: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Country/Sub-region, 2020-2034
  • Table 27: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Treatment Type, 2020-2034
  • Table 28: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Route of Administration, 2020-2034
  • Table 29: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Disease Indication, 2020-2034
  • Table 30: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast, by Distribution Channel, 2020-2034

List of Figures

  • Figure 01: Global Hormone Replacement Therapy Market Size (US$ Bn), by Region, 2023 and 2034
  • Figure 02: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Treatment Type, 2023
  • Figure 03: Global Hormone Replacement Therapy Market Value Share, by Treatment Type, 2023
  • Figure 04: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Route of Administration, 2023
  • Figure 05: Global Hormone Replacement Therapy Market Value Share, by Route of Administration, 2023
  • Figure 06: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Disease Indication, 2023
  • Figure 07: Global Hormone Replacement Therapy Market Value Share, by Disease Indication, 2023
  • Figure 08: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 09: Global Hormone Replacement Therapy Market Value Share, by Distribution Channel, 2023
  • Figure 10: Global Hormone Replacement Therapy Market Value Share, by Region, 2023
  • Figure 11: Global Hormone Replacement Therapy Market Value (US$ Bn) Forecast, 2020-2034
  • Figure 12: Global Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 13: Global Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 14: Global Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 15: Global Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 16: Global Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 17: Global Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 18: Global Hormone Replacement Therapy Market Revenue (US$ Bn), by Distribution Channel, 2023
  • Figure 19: Global Hormone Replacement Therapy Market Value Share, by Distribution Channel, 2023
  • Figure 20: Global Hormone Replacement Therapy Market Value Share Analysis, by Region, 2023 and 2034
  • Figure 21: Global Hormone Replacement Therapy Market Attractiveness Analysis, by Region, 2024-2034
  • Figure 22: North America Hormone Replacement Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 23: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Country, 2024-2034
  • Figure 24: North America Hormone Replacement Therapy Market Value Share Analysis, by Country, 2023 and 2034
  • Figure 25: North America Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 26: North America Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 27: North America Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 28: North America Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 29: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 30: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 31: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 32: North America Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 33: Europe Hormone Replacement Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 34: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 35: Europe Hormone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 36: Europe Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 37: Europe Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 38: Europe Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 39: Europe Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 40: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 41: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 42: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 43: Europe Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 44: Asia Pacific Hormone Replacement Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 45: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 46: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 47: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 48: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 49: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 50: Asia Pacific Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 51: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 52: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 53: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 54: Asia Pacific Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2023-2034
  • Figure 55: Latin America Hormone Replacement Therapy Market Value (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 56: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 57: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 58: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 59: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 60: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 61: Latin America Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 62: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 63: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 64: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 65: Latin America Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2024-2034
  • Figure 66: Middle East & Africa Hormone Replacement Therapy Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2020-2034
  • Figure 67: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
  • Figure 68: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
  • Figure 69: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Treatment Type, 2023 and 2034
  • Figure 70: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Route of Administration, 2023 and 2034
  • Figure 71: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Disease Indication, 2023 and 2034
  • Figure 72: Middle East & Africa Hormone Replacement Therapy Market Value Share Analysis, by Distribution Channel, 2023 and 2034
  • Figure 73: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Treatment Type, 2024-2034
  • Figure 74: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Route of Administration, 2024-2034
  • Figure 75: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Disease Indication, 2024-2034
  • Figure 76: Middle East & Africa Hormone Replacement Therapy Market Attractiveness Analysis, by Distribution Channel, 2024-2034
目次
Product Code: TMRGL610

Hormone Replacement Therapy Market - Scope of Report

TMR's report on the global hormone replacement therapy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global hormone replacement therapy market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hormone replacement therapy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the hormone replacement therapy market.

Market Snapshot
Market Value in 2023US$ 21 Bn
Market Value in 2034US$ 38.8 Bn
CAGR5.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hormone replacement therapy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global hormone replacement therapy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hormone replacement therapy market.

The report delves into the competitive landscape of the global hormone replacement therapy market. Key players operating in the global hormone replacement therapy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hormone replacement therapy market profiled in this report.

Key Questions Answered in Global hormone replacement therapy Market Report:

  • What is the sales/revenue generated by hormone replacement therapy across all regions during the forecast period?
  • What are the opportunities in the global hormone replacement therapy market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Hormone Replacement Therapy Market - Research Objectives and Research Approach

The comprehensive report on the global hormone replacement therapy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global hormone replacement therapy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hormone replacement therapy market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hormone Replacement Therapy Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Hormone Replacement Therapy Market Analysis and Forecast, 2020-2034

5. Key Insights

  • 5.1. Pipeline Analysis
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Mergers & Acquisitions
  • 5.4. COVID-19 Pandemic Impact on Industry

6. Global Hormone Replacement Therapy Market Analysis and Forecast, by Treatment Type

  • 6.1. Introduction and Definitions
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Treatment Type, 2020-2034
    • 6.3.1. Human Growth Hormone (HGH) Replacement Therapy
    • 6.3.2. Thyroid Replacement Therapy
    • 6.3.3. Testosterone Replacement Therapy
    • 6.3.4. Dopamine Agonist
    • 6.3.5. Somatostatin Analogue
    • 6.3.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 6.4. Market Attractiveness, by Treatment Type

7. Global Hormone Replacement Therapy Market Analysis and Forecast, by Route of Administration

  • 7.1. Introduction and Definitions
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Route of Administration, 2020-2034
    • 7.3.1. Oral
    • 7.3.2. Parenteral
    • 7.3.3. Transdermal
  • 7.4. Market Attractiveness, by Route of Administration

8. Global Hormone Replacement Therapy Market Analysis and Forecast, by Disease Indication

  • 8.1. Introduction and Definitions
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Disease Indication, 2020-2034
    • 8.3.1. Menopause
    • 8.3.2. Hypothyroidism
    • 8.3.3. Male Hypogonadism
    • 8.3.4. Growth Hormone Deficiency
    • 8.3.5. Hypoparathyroidism
  • 8.4. Market Attractiveness, by Disease Indication

9. Global Hormone Replacement Therapy Market Analysis and Forecast, by Distribution Channel

  • 9.1. Introduction and Definitions
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by Distribution Channel, 2020-2034
    • 9.3.1. Hospital Pharmacies
    • 9.3.2. Retail Pharmacies
    • 9.3.3. Online Pharmacies
  • 9.4. Market Attractiveness, by Distribution Channel

10. Global Hormone Replacement Therapy Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2020-2034
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness, by Region

11. North America Hormone Replacement Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 11.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 11.2.2. Thyroid Replacement Therapy
    • 11.2.3. Testosterone Replacement Therapy
    • 11.2.4. Dopamine Agonist
    • 11.2.5. Somatostatin Analogue
    • 11.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 11.3. Market Attractiveness, by Treatment Type
  • 11.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 11.4.1. Oral
    • 11.4.2. Parenteral
    • 11.4.3. Transdermal
  • 11.5. Market Attractiveness, by Route of Administration
  • 11.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 11.6.1. Menopause
    • 11.6.2. Hypothyroidism
    • 11.6.3. Male Hypogonadism
    • 11.6.4. Growth Hormone Deficiency
    • 11.6.5. Hypoparathyroidism
  • 11.7. Market Attractiveness, by Disease Indication
  • 11.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 11.8.1. Hospital Pharmacies
    • 11.8.2. Retail Pharmacies
    • 11.8.3. Online Pharmacies
  • 11.9. Market Attractiveness, by Distribution Channel
  • 11.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 11.10.1. U.S.
    • 11.10.2. Canada
  • 11.11. Market Attractiveness Analysis
    • 11.11.1. By Treatment Type
    • 11.11.2. By Route of Administration
    • 11.11.3. By Disease Indication
    • 11.11.4. By Distribution Channel
    • 11.11.5. By Country

12. Europe Hormone Replacement Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 12.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 12.2.2. Thyroid Replacement Therapy
    • 12.2.3. Testosterone Replacement Therapy
    • 12.2.4. Dopamine Agonist
    • 12.2.5. Somatostatin Analogue
    • 12.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 12.3. Market Attractiveness, by Treatment Type
  • 12.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 12.4.1. Oral
    • 12.4.2. Parenteral
    • 12.4.3. Transdermal
  • 12.5. Market Attractiveness, by Route of Administration
  • 12.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 12.6.1. Menopause
    • 12.6.2. Hypothyroidism
    • 12.6.3. Male Hypogonadism
    • 12.6.4. Growth Hormone Deficiency
    • 12.6.5. Hypoparathyroidism
  • 12.7. Market Attractiveness, by Disease Indication
  • 12.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 12.8.1. Hospital Pharmacies
    • 12.8.2. Retail Pharmacies
    • 12.8.3. Online Pharmacies
  • 12.9. Market Attractiveness, by Distribution Channel
  • 12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 12.10.1. Germany
    • 12.10.2. U.K.
    • 12.10.3. France
    • 12.10.4. Italy
    • 12.10.5. Spain
    • 12.10.6. Rest of Europe
  • 12.11. Market Attractiveness Analysis
    • 12.11.1. By Treatment Type
    • 12.11.2. By Route of Administration
    • 12.11.3. By Disease Indication
    • 12.11.4. By Distribution Channel
    • 12.11.5. By Country/Sub-region

13. Asia Pacific Hormone Replacement Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 13.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 13.2.2. Thyroid Replacement Therapy
    • 13.2.3. Testosterone Replacement Therapy
    • 13.2.4. Dopamine Agonist
    • 13.2.5. Somatostatin Analogue
    • 13.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 13.3. Market Attractiveness, by Treatment Type
  • 13.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 13.4.1. Oral
    • 13.4.2. Parenteral
    • 13.4.3. Transdermal
  • 13.5. Market Attractiveness, by Route of Administration
  • 13.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 13.6.1. Menopause
    • 13.6.2. Hypothyroidism
    • 13.6.3. Male Hypogonadism
    • 13.6.4. Growth Hormone Deficiency
    • 13.6.5. Hypoparathyroidism
  • 13.7. Market Attractiveness, by Disease Indication
  • 13.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 13.8.1. Hospital Pharmacies
    • 13.8.2. Retail Pharmacies
    • 13.8.3. Online Pharmacies
  • 13.9. Market Attractiveness, by Distribution Channel
  • 13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 13.10.1. China
    • 13.10.2. Japan
    • 13.10.3. India
    • 13.10.4. Australia & New Zealand
    • 13.10.5. Rest of Asia Pacific
  • 13.11. Market Attractiveness Analysis
    • 13.11.1. By Treatment Type
    • 13.11.2. By Route of Administration
    • 13.11.3. By Disease Indication
    • 13.11.4. By Distribution Channel
    • 13.11.5. By Country/Sub-region

14. Latin America Hormone Replacement Therapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 14.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 14.2.2. Thyroid Replacement Therapy
    • 14.2.3. Testosterone Replacement Therapy
    • 14.2.4. Dopamine Agonist
    • 14.2.5. Somatostatin Analogue
    • 14.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 14.3. Market Attractiveness, by Treatment Type
  • 14.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 14.4.1. Oral
    • 14.4.2. Parenteral
    • 14.4.3. Transdermal
  • 14.5. Market Attractiveness, by Route of Administration
  • 14.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 14.6.1. Menopause
    • 14.6.2. Hypothyroidism
    • 14.6.3. Male Hypogonadism
    • 14.6.4. Growth Hormone Deficiency
    • 14.6.5. Hypoparathyroidism
  • 14.7. Market Attractiveness, by Disease Indication
  • 14.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 14.8.1. Hospital Pharmacies
    • 14.8.2. Retail Pharmacies
    • 14.8.3. Online Pharmacies
  • 14.9. Market Attractiveness, by Distribution Channel
  • 14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 14.10.1. Brazil
    • 14.10.2. Mexico
    • 14.10.3. Rest of Latin America
  • 14.11. Market Attractiveness Analysis
    • 14.11.1. By Treatment Type
    • 14.11.2. By Route of Administration
    • 14.11.3. By Disease Indication
    • 14.11.4. By Distribution Channel
    • 14.11.5. By Country/Sub-region

15. Middle East & Africa Hormone Replacement Therapy Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Treatment Type, 2020-2034
    • 15.2.1. Human Growth Hormone (HGH) Replacement Therapy
    • 15.2.2. Thyroid Replacement Therapy
    • 15.2.3. Testosterone Replacement Therapy
    • 15.2.4. Dopamine Agonist
    • 15.2.5. Somatostatin Analogue
    • 15.2.6. Others (Parathyroid Hormone Replacement Therapy, etc.)
  • 15.3. Market Attractiveness, by Treatment Type
  • 15.4. Market Value Forecast, by Route of Administration, 2020-2034
    • 15.4.1. Oral
    • 15.4.2. Parenteral
    • 15.4.3. Transdermal
  • 15.5. Market Attractiveness, by Route of Administration
  • 15.6. Market Value Forecast, by Disease Indication, 2020-2034
    • 15.6.1. Menopause
    • 15.6.2. Hypothyroidism
    • 15.6.3. Male Hypogonadism
    • 15.6.4. Growth Hormone Deficiency
    • 15.6.5. Hypoparathyroidism
  • 15.7. Market Attractiveness, by Disease Indication
  • 15.8. Market Value Forecast, by Distribution Channel, 2020-2034
    • 15.8.1. Hospital Pharmacies
    • 15.8.2. Retail Pharmacies
    • 15.8.3. Online Pharmacies
  • 15.9. Market Attractiveness, by Distribution Channel
  • 15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
    • 15.10.1. GCC Countries
    • 15.10.2. South Africa
    • 15.10.3. Rest of Middle East & Africa
  • 15.11. Market Attractiveness Analysis
    • 15.11.1. By Treatment Type
    • 15.11.2. By Route of Administration
    • 15.11.3. By Disease Indication
    • 15.11.4. By Distribution Channel
    • 15.11.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2023)
  • 16.3. Company Profiles
    • 16.3.1. Novartis AG
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Abbott Laboratories
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Mylan N.V.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Merck & Co., Inc.
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Bayer AG
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. Pfizer Inc.
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Novo Nordisk A/S
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. QuatRx Pharmaceuticals Co.
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview
    • 16.3.9. Teva Pharmaceutical Industries Ltd.
      • 16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.9.2. Product Portfolio
      • 16.3.9.3. Financial Overview
      • 16.3.9.4. SWOT Analysis
      • 16.3.9.5. Strategic Overview
    • 16.3.10. Amgen Inc.
      • 16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.10.2. Product Portfolio
      • 16.3.10.3. Financial Overview
      • 16.3.10.4. SWOT Analysis
      • 16.3.10.5. Strategic Overview
    • 16.3.11. Eli, Lilly and Company
      • 16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.11.2. Product Portfolio
      • 16.3.11.3. Financial Overview
      • 16.3.11.4. SWOT Analysis
      • 16.3.11.5. Strategic Overview
    • 16.3.12. AbbVie Inc.
      • 16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.12.2. Product Portfolio
      • 16.3.12.3. Financial Overview
      • 16.3.12.4. SWOT Analysis
      • 16.3.12.5. Strategic Overview
    • 16.3.13. Noven Pharmaceuticals
      • 16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.13.2. Product Portfolio
      • 16.3.13.3. Financial Overview
      • 16.3.13.4. SWOT Analysis
      • 16.3.13.5. Strategic Overview